Global Mesenchymal Stem Cells Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
According to APO Research, The global Mesenchymal Stem Cells market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Mesenchymal Stem Cells include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen and Cell Applications, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Mesenchymal Stem Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
According to APO Research, The global Mesenchymal Stem Cells market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Mesenchymal Stem Cells is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Mesenchymal Stem Cells include Lonza, Thermo Fisher, Bio-Techne, ATCC, MilliporeSigma, PromoCell GmbH, Genlantis, Celprogen and Cell Applications, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells.
The Mesenchymal Stem Cells market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mesenchymal Stem Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Lonza
- Thermo Fisher
- Bio-Techne
- ATCC
- MilliporeSigma
- PromoCell GmbH
- Genlantis
- Celprogen
- Cell Applications
- Cyagen Biosciences
- Axol Bioscience
- Human MSC
- Mouse MSC
- Rat MSC
- Others
- Research Institute
- Hospital
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Mesenchymal Stem Cells companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Mesenchymal Stem Cells Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Mesenchymal Stem Cells Market Size by Region (2019-2030)
1.4.1 Global Mesenchymal Stem Cells Market Size by Region (2019-2024)
1.4.2 Global Mesenchymal Stem Cells Market Size by Region (2025-2030)
1.5 Key Regions Mesenchymal Stem Cells Market Size (2019-2030)
1.5.1 North America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.2 Europe Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.4 Latin America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
2 MESENCHYMAL STEM CELLS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Human MSC
2.1.2 Mouse MSC
2.1.3 Rat MSC
2.1.4 Others
2.2 Global Mesenchymal Stem Cells Market Size by Type
2.2.1 Global Mesenchymal Stem Cells Market Size Overview by Type (2019-2030)
2.2.2 Global Mesenchymal Stem Cells Historic Market Size Review by Type (2019-2024)
2.2.3 Global Mesenchymal Stem Cells Market Size Forecasted by Type (2025-2030)
2.3 Global Mesenchymal Stem Cells Market Size by Regions
2.3.1 North America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
3 MESENCHYMAL STEM CELLS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Research Institute
3.1.2 Hospital
3.1.3 Others
3.2 Global Mesenchymal Stem Cells Market Size by Application
3.2.1 Global Mesenchymal Stem Cells Market Size Overview by Application (2019-2030)
3.2.2 Global Mesenchymal Stem Cells Historic Market Size Review by Application (2019-2024)
3.2.3 Global Mesenchymal Stem Cells Market Size Forecasted by Application (2025-2030)
3.3 Global Mesenchymal Stem Cells Market Size by Regions
3.3.1 North America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Mesenchymal Stem Cells Industry Trends
4.2 Mesenchymal Stem Cells Industry Drivers
4.3 Mesenchymal Stem Cells Industry Opportunities and Challenges
4.4 Mesenchymal Stem Cells Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Mesenchymal Stem Cells Revenue (2019-2024)
5.2 Global Mesenchymal Stem Cells Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Mesenchymal Stem Cells Key Company Headquarters & Area Served
5.4 Global Mesenchymal Stem Cells Company, Product Type & Application
5.5 Global Mesenchymal Stem Cells Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Mesenchymal Stem Cells Market CR5 and HHI
5.6.2 Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2023
5.6.3 2023 Mesenchymal Stem Cells Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Lonza
6.1.1 Lonza Comapny Information
6.1.2 Lonza Business Overview
6.1.3 Lonza Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
6.1.5 Lonza Recent Developments
6.2 Thermo Fisher
6.2.1 Thermo Fisher Comapny Information
6.2.2 Thermo Fisher Business Overview
6.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
6.2.5 Thermo Fisher Recent Developments
6.3 Bio-Techne
6.3.1 Bio-Techne Comapny Information
6.3.2 Bio-Techne Business Overview
6.3.3 Bio-Techne Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
6.3.5 Bio-Techne Recent Developments
6.4 ATCC
6.4.1 ATCC Comapny Information
6.4.2 ATCC Business Overview
6.4.3 ATCC Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
6.4.5 ATCC Recent Developments
6.5 MilliporeSigma
6.5.1 MilliporeSigma Comapny Information
6.5.2 MilliporeSigma Business Overview
6.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
6.5.5 MilliporeSigma Recent Developments
6.6 PromoCell GmbH
6.6.1 PromoCell GmbH Comapny Information
6.6.2 PromoCell GmbH Business Overview
6.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
6.6.5 PromoCell GmbH Recent Developments
6.7 Genlantis
6.7.1 Genlantis Comapny Information
6.7.2 Genlantis Business Overview
6.7.3 Genlantis Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
6.7.5 Genlantis Recent Developments
6.8 Celprogen
6.8.1 Celprogen Comapny Information
6.8.2 Celprogen Business Overview
6.8.3 Celprogen Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
6.8.5 Celprogen Recent Developments
6.9 Cell Applications
6.9.1 Cell Applications Comapny Information
6.9.2 Cell Applications Business Overview
6.9.3 Cell Applications Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
6.9.5 Cell Applications Recent Developments
6.10 Cyagen Biosciences
6.10.1 Cyagen Biosciences Comapny Information
6.10.2 Cyagen Biosciences Business Overview
6.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
6.10.5 Cyagen Biosciences Recent Developments
6.11 Axol Bioscience
6.11.1 Axol Bioscience Comapny Information
6.11.2 Axol Bioscience Business Overview
6.11.3 Axol Bioscience Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
6.11.5 Axol Bioscience Recent Developments
7 NORTH AMERICA
7.1 North America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Mesenchymal Stem Cells Market Size by Country (2019-2024)
7.3 North America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Mesenchymal Stem Cells Market Size by Country (2019-2024)
8.3 Europe Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2019-2024)
9.3 Asia-Pacific Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024)
10.3 Latin America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024)
11.3 Middle East & Africa Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Mesenchymal Stem Cells Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Mesenchymal Stem Cells Market Size by Region (2019-2030)
1.4.1 Global Mesenchymal Stem Cells Market Size by Region (2019-2024)
1.4.2 Global Mesenchymal Stem Cells Market Size by Region (2025-2030)
1.5 Key Regions Mesenchymal Stem Cells Market Size (2019-2030)
1.5.1 North America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.2 Europe Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.4 Latin America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (2019-2030)
2 MESENCHYMAL STEM CELLS MARKET BY TYPE
2.1 Type Introduction
2.1.1 Human MSC
2.1.2 Mouse MSC
2.1.3 Rat MSC
2.1.4 Others
2.2 Global Mesenchymal Stem Cells Market Size by Type
2.2.1 Global Mesenchymal Stem Cells Market Size Overview by Type (2019-2030)
2.2.2 Global Mesenchymal Stem Cells Historic Market Size Review by Type (2019-2024)
2.2.3 Global Mesenchymal Stem Cells Market Size Forecasted by Type (2025-2030)
2.3 Global Mesenchymal Stem Cells Market Size by Regions
2.3.1 North America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024)
3 MESENCHYMAL STEM CELLS MARKET BY APPLICATION
3.1 Type Introduction
3.1.1 Research Institute
3.1.2 Hospital
3.1.3 Others
3.2 Global Mesenchymal Stem Cells Market Size by Application
3.2.1 Global Mesenchymal Stem Cells Market Size Overview by Application (2019-2030)
3.2.2 Global Mesenchymal Stem Cells Historic Market Size Review by Application (2019-2024)
3.2.3 Global Mesenchymal Stem Cells Market Size Forecasted by Application (2025-2030)
3.3 Global Mesenchymal Stem Cells Market Size by Regions
3.3.1 North America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024)
4 GLOBAL MARKET DYNAMICS
4.1 Mesenchymal Stem Cells Industry Trends
4.2 Mesenchymal Stem Cells Industry Drivers
4.3 Mesenchymal Stem Cells Industry Opportunities and Challenges
4.4 Mesenchymal Stem Cells Industry Restraints
5 COMPETITIVE INSIGHTS BY COMPANY
5.1 Global Top Players by Mesenchymal Stem Cells Revenue (2019-2024)
5.2 Global Mesenchymal Stem Cells Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Mesenchymal Stem Cells Key Company Headquarters & Area Served
5.4 Global Mesenchymal Stem Cells Company, Product Type & Application
5.5 Global Mesenchymal Stem Cells Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Mesenchymal Stem Cells Market CR5 and HHI
5.6.2 Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2023
5.6.3 2023 Mesenchymal Stem Cells Tier 1, Tier 2, and Tier
6 COMPANY PROFILES
6.1 Lonza
6.1.1 Lonza Comapny Information
6.1.2 Lonza Business Overview
6.1.3 Lonza Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
6.1.5 Lonza Recent Developments
6.2 Thermo Fisher
6.2.1 Thermo Fisher Comapny Information
6.2.2 Thermo Fisher Business Overview
6.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
6.2.5 Thermo Fisher Recent Developments
6.3 Bio-Techne
6.3.1 Bio-Techne Comapny Information
6.3.2 Bio-Techne Business Overview
6.3.3 Bio-Techne Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
6.3.5 Bio-Techne Recent Developments
6.4 ATCC
6.4.1 ATCC Comapny Information
6.4.2 ATCC Business Overview
6.4.3 ATCC Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
6.4.5 ATCC Recent Developments
6.5 MilliporeSigma
6.5.1 MilliporeSigma Comapny Information
6.5.2 MilliporeSigma Business Overview
6.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
6.5.5 MilliporeSigma Recent Developments
6.6 PromoCell GmbH
6.6.1 PromoCell GmbH Comapny Information
6.6.2 PromoCell GmbH Business Overview
6.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
6.6.5 PromoCell GmbH Recent Developments
6.7 Genlantis
6.7.1 Genlantis Comapny Information
6.7.2 Genlantis Business Overview
6.7.3 Genlantis Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
6.7.5 Genlantis Recent Developments
6.8 Celprogen
6.8.1 Celprogen Comapny Information
6.8.2 Celprogen Business Overview
6.8.3 Celprogen Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
6.8.5 Celprogen Recent Developments
6.9 Cell Applications
6.9.1 Cell Applications Comapny Information
6.9.2 Cell Applications Business Overview
6.9.3 Cell Applications Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
6.9.5 Cell Applications Recent Developments
6.10 Cyagen Biosciences
6.10.1 Cyagen Biosciences Comapny Information
6.10.2 Cyagen Biosciences Business Overview
6.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
6.10.5 Cyagen Biosciences Recent Developments
6.11 Axol Bioscience
6.11.1 Axol Bioscience Comapny Information
6.11.2 Axol Bioscience Business Overview
6.11.3 Axol Bioscience Mesenchymal Stem Cells Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
6.11.5 Axol Bioscience Recent Developments
7 NORTH AMERICA
7.1 North America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Mesenchymal Stem Cells Market Size by Country (2019-2024)
7.3 North America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
8 EUROPE
8.1 Europe Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Mesenchymal Stem Cells Market Size by Country (2019-2024)
8.3 Europe Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2019-2024)
9.3 Asia-Pacific Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA
10.1 Latin America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024)
10.3 Latin America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024)
11.3 Middle East & Africa Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030)
12 CONCLUDING INSIGHTS
13 APPENDIX
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
LIST OF TABLES
Table 1. Global Mesenchymal Stem Cells Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Mesenchymal Stem Cells Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Mesenchymal Stem Cells Market Share by Region (2019-2024)
Table 4. Global Mesenchymal Stem Cells Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Mesenchymal Stem Cells Market Share by Region (2025-2030)
Table 6. Global Mesenchymal Stem Cells Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Mesenchymal Stem Cells Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Mesenchymal Stem Cells Market Size Share by Type (2019-2024)
Table 9. Global Mesenchymal Stem Cells Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Mesenchymal Stem Cells Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Mesenchymal Stem Cells Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Mesenchymal Stem Cells Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Mesenchymal Stem Cells Market Size Share by Application (2019-2024)
Table 24. Global Mesenchymal Stem Cells Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Mesenchymal Stem Cells Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Mesenchymal Stem Cells Industry Trends
Table 37. Mesenchymal Stem Cells Industry Drivers
Table 38. Mesenchymal Stem Cells Industry Opportunities and Challenges
Table 39. Mesenchymal Stem Cells Industry Restraints
Table 40. Global Mesenchymal Stem Cells Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Mesenchymal Stem Cells Revenue Market Share by Company (2019-2024)
Table 42. Global Mesenchymal Stem Cells Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Mesenchymal Stem Cells Key Company Headquarters & Area Served
Table 44. Global Mesenchymal Stem Cells Company, Product Type & Application
Table 45. Global Mesenchymal Stem Cells Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Mesenchymal Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Lonza Business Overview
Table 49. Lonza Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Lonza Mesenchymal Stem Cells Product Portfolio
Table 51. Lonza Recent Development
Table 52. Thermo Fisher Company Information
Table 53. Thermo Fisher Business Overview
Table 54. Thermo Fisher Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Thermo Fisher Mesenchymal Stem Cells Product Portfolio
Table 56. Thermo Fisher Recent Development
Table 57. Bio-Techne Company Information
Table 58. Bio-Techne Business Overview
Table 59. Bio-Techne Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Bio-Techne Mesenchymal Stem Cells Product Portfolio
Table 61. Bio-Techne Recent Development
Table 62. ATCC Company Information
Table 63. ATCC Business Overview
Table 64. ATCC Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. ATCC Mesenchymal Stem Cells Product Portfolio
Table 66. ATCC Recent Development
Table 67. MilliporeSigma Company Information
Table 68. MilliporeSigma Business Overview
Table 69. MilliporeSigma Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. MilliporeSigma Mesenchymal Stem Cells Product Portfolio
Table 71. MilliporeSigma Recent Development
Table 72. PromoCell GmbH Company Information
Table 73. PromoCell GmbH Business Overview
Table 74. PromoCell GmbH Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
Table 76. PromoCell GmbH Recent Development
Table 77. Genlantis Company Information
Table 78. Genlantis Business Overview
Table 79. Genlantis Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Genlantis Mesenchymal Stem Cells Product Portfolio
Table 81. Genlantis Recent Development
Table 82. Celprogen Company Information
Table 83. Celprogen Business Overview
Table 84. Celprogen Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Celprogen Mesenchymal Stem Cells Product Portfolio
Table 86. Celprogen Recent Development
Table 87. Cell Applications Company Information
Table 88. Cell Applications Business Overview
Table 89. Cell Applications Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Cell Applications Mesenchymal Stem Cells Product Portfolio
Table 91. Cell Applications Recent Development
Table 92. Cyagen Biosciences Company Information
Table 93. Cyagen Biosciences Business Overview
Table 94. Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
Table 96. Cyagen Biosciences Recent Development
Table 97. Axol Bioscience Company Information
Table 98. Axol Bioscience Business Overview
Table 99. Axol Bioscience Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Axol Bioscience Mesenchymal Stem Cells Product Portfolio
Table 101. Axol Bioscience Recent Development
Table 102. North America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. North America Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 104. North America Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 105. North America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. North America Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 107. Europe Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. Europe Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 109. Europe Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 110. Europe Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. Europe Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 112. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 114. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 115. Asia-Pacific Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Asia-Pacific Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 117. Latin America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 119. Latin America Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 120. Latin America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Latin America Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 122. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 124. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 125. Middle East & Africa Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 127. Research Programs/Design for This Report
Table 128. Authors List of This Report
Table 129. Secondary Sources
Table 130. Primary Sources
Table 1. Global Mesenchymal Stem Cells Market Size (US$ Million) Comparison by Region: 2019 VS 2023 VS 2030
Table 2. Global Mesenchymal Stem Cells Market Size by Region (2019-2024) & (US$ Million)
Table 3. Global Mesenchymal Stem Cells Market Share by Region (2019-2024)
Table 4. Global Mesenchymal Stem Cells Market Size by Region (2025-2030) & (US$ Million)
Table 5. Global Mesenchymal Stem Cells Market Share by Region (2025-2030)
Table 6. Global Mesenchymal Stem Cells Market Size by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 7. Global Mesenchymal Stem Cells Market Size by Type (2019-2024) & (US$ Million)
Table 8. Global Mesenchymal Stem Cells Market Size Share by Type (2019-2024)
Table 9. Global Mesenchymal Stem Cells Market Size Forecasted by Type (2025-2030) & (US$ Million)
Table 10. Global Mesenchymal Stem Cells Market Size Share Forecasted by Type (2025-2030)
Table 11. North America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 12. North America Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 13. Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 14. Europe Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 15. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 16. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 17. Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 18. Latin America Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 19. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2019-2024) & (US$ Million)
Table 20. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Type (2025-2030) & (US$ Million)
Table 21. Global Mesenchymal Stem Cells Market Size by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 22. Global Mesenchymal Stem Cells Market Size by Application (2019-2024) & (US$ Million)
Table 23. Global Mesenchymal Stem Cells Market Size Share by Application (2019-2024)
Table 24. Global Mesenchymal Stem Cells Market Size Forecasted by Application (2025-2030) & (US$ Million)
Table 25. Global Mesenchymal Stem Cells Market Size Share Forecasted by Application (2025-2030)
Table 26. North America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 27. North America Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 28. Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 29. Europe Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 30. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 31. Asia-Pacific Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 32. Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 33. Latin America Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 34. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2019-2024) & (US$ Million)
Table 35. Middle East and Africa Mesenchymal Stem Cells Market Size Breakdown by Application (2025-2030) & (US$ Million)
Table 36. Mesenchymal Stem Cells Industry Trends
Table 37. Mesenchymal Stem Cells Industry Drivers
Table 38. Mesenchymal Stem Cells Industry Opportunities and Challenges
Table 39. Mesenchymal Stem Cells Industry Restraints
Table 40. Global Mesenchymal Stem Cells Revenue by Company (US$ Million) & (2019-2024)
Table 41. Global Mesenchymal Stem Cells Revenue Market Share by Company (2019-2024)
Table 42. Global Mesenchymal Stem Cells Industry Company Ranking, 2022 VS 2023 VS 2024
Table 43. Global Mesenchymal Stem Cells Key Company Headquarters & Area Served
Table 44. Global Mesenchymal Stem Cells Company, Product Type & Application
Table 45. Global Mesenchymal Stem Cells Company Commercialization Time
Table 46. Global Company Market Concentration Ratio (CR5 and HHI)
Table 47. Global Mesenchymal Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 48. Lonza Business Overview
Table 49. Lonza Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 50. Lonza Mesenchymal Stem Cells Product Portfolio
Table 51. Lonza Recent Development
Table 52. Thermo Fisher Company Information
Table 53. Thermo Fisher Business Overview
Table 54. Thermo Fisher Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 55. Thermo Fisher Mesenchymal Stem Cells Product Portfolio
Table 56. Thermo Fisher Recent Development
Table 57. Bio-Techne Company Information
Table 58. Bio-Techne Business Overview
Table 59. Bio-Techne Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 60. Bio-Techne Mesenchymal Stem Cells Product Portfolio
Table 61. Bio-Techne Recent Development
Table 62. ATCC Company Information
Table 63. ATCC Business Overview
Table 64. ATCC Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 65. ATCC Mesenchymal Stem Cells Product Portfolio
Table 66. ATCC Recent Development
Table 67. MilliporeSigma Company Information
Table 68. MilliporeSigma Business Overview
Table 69. MilliporeSigma Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 70. MilliporeSigma Mesenchymal Stem Cells Product Portfolio
Table 71. MilliporeSigma Recent Development
Table 72. PromoCell GmbH Company Information
Table 73. PromoCell GmbH Business Overview
Table 74. PromoCell GmbH Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 75. PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
Table 76. PromoCell GmbH Recent Development
Table 77. Genlantis Company Information
Table 78. Genlantis Business Overview
Table 79. Genlantis Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 80. Genlantis Mesenchymal Stem Cells Product Portfolio
Table 81. Genlantis Recent Development
Table 82. Celprogen Company Information
Table 83. Celprogen Business Overview
Table 84. Celprogen Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 85. Celprogen Mesenchymal Stem Cells Product Portfolio
Table 86. Celprogen Recent Development
Table 87. Cell Applications Company Information
Table 88. Cell Applications Business Overview
Table 89. Cell Applications Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 90. Cell Applications Mesenchymal Stem Cells Product Portfolio
Table 91. Cell Applications Recent Development
Table 92. Cyagen Biosciences Company Information
Table 93. Cyagen Biosciences Business Overview
Table 94. Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 95. Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
Table 96. Cyagen Biosciences Recent Development
Table 97. Axol Bioscience Company Information
Table 98. Axol Bioscience Business Overview
Table 99. Axol Bioscience Mesenchymal Stem Cells Revenue (US$ Million), Global Share (%) and Gross Margin (2019-2024)
Table 100. Axol Bioscience Mesenchymal Stem Cells Product Portfolio
Table 101. Axol Bioscience Recent Development
Table 102. North America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 103. North America Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 104. North America Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 105. North America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 106. North America Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 107. Europe Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 108. Europe Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 109. Europe Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 110. Europe Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 111. Europe Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 112. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 113. Asia-Pacific Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 114. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 115. Asia-Pacific Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 116. Asia-Pacific Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 117. Latin America Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 118. Latin America Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 119. Latin America Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 120. Latin America Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 121. Latin America Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 122. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 123. Middle East & Africa Mesenchymal Stem Cells Market Size by Country (2019-2024) & (US$ Million)
Table 124. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2019-2024)
Table 125. Middle East & Africa Mesenchymal Stem Cells Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 126. Middle East & Africa Mesenchymal Stem Cells Market Share Forecast by Country (2025-2030)
Table 127. Research Programs/Design for This Report
Table 128. Authors List of This Report
Table 129. Secondary Sources
Table 130. Primary Sources
LIST OF FIGURES
Figure 1. Mesenchymal Stem Cells Product Picture
Figure 2. Global Mesenchymal Stem Cells Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Mesenchymal Stem Cells Market Size (2019-2030) & (US$ Million)
Figure 4. Global Mesenchymal Stem Cells Market Share by Region: 2023 VS 2030
Figure 5. Global Mesenchymal Stem Cells Market Share by Region (2019-2030)
Figure 6. North America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Human MSC
Figure 12. Global Human MSC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Mouse MSC
Figure 14. Global Mouse MSC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Rat MSC
Figure 16. Global Rat MSC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Others
Figure 18. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Global Mesenchymal Stem Cells Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 20. Global Mesenchymal Stem Cells Market Share by Type 2023 VS 2030
Figure 21. North America Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 22. Europe Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 23. Asia-Pacific Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 24. Latin America Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 25. Middle East and Africa Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 26. Product Picture of Research Institute
Figure 27. Global Research Institute Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Others
Figure 31. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Mesenchymal Stem Cells Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Mesenchymal Stem Cells Market Share by Application 2023 VS 2030
Figure 34. North America Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 35. Europe Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 37. Latin America Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 44. Europe Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 50. Latin America Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed
Figure 1. Mesenchymal Stem Cells Product Picture
Figure 2. Global Mesenchymal Stem Cells Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Mesenchymal Stem Cells Market Size (2019-2030) & (US$ Million)
Figure 4. Global Mesenchymal Stem Cells Market Share by Region: 2023 VS 2030
Figure 5. Global Mesenchymal Stem Cells Market Share by Region (2019-2030)
Figure 6. North America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 7. Europe Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 8. Asia-Pacific Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 9. Latin America Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 10. Middle East & Africa Mesenchymal Stem Cells Market Size Growth Rate (2019-2030) & (US$ Million)
Figure 11. Product Picture of Human MSC
Figure 12. Global Human MSC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 13. Product Picture of Mouse MSC
Figure 14. Global Mouse MSC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 15. Product Picture of Rat MSC
Figure 16. Global Rat MSC Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. Product Picture of Others
Figure 18. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Global Mesenchymal Stem Cells Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 20. Global Mesenchymal Stem Cells Market Share by Type 2023 VS 2030
Figure 21. North America Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 22. Europe Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 23. Asia-Pacific Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 24. Latin America Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 25. Middle East and Africa Mesenchymal Stem Cells Market Size Share by Type (2019-2030)
Figure 26. Product Picture of Research Institute
Figure 27. Global Research Institute Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Product Picture of Others
Figure 31. Global Others Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Global Mesenchymal Stem Cells Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 33. Global Mesenchymal Stem Cells Market Share by Application 2023 VS 2030
Figure 34. North America Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 35. Europe Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 36. Asia-Pacific Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 37. Latin America Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 38. Middle East and Africa Mesenchymal Stem Cells Market Size Share by Application (2019-2030)
Figure 39. Global Top 5 and 10 Mesenchymal Stem Cells Players Market Share by Revenue in 2023
Figure 40. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 41. North America Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 42. North America Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 44. Europe Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 45. Europe Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 46. Europe Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 47. Asia-Pacific Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Asia-Pacific Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 50. Latin America Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Latin America Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 52. Latin America Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Mesenchymal Stem Cells Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 54. Middle East & Africa Mesenchymal Stem Cells Market Share by Country: 2019 VS 2023 VS 2030
Figure 55. Middle East & Africa Mesenchymal Stem Cells Market Share by Country (2019-2030)
Figure 56. Years Considered
Figure 57. Research Process
Figure 58. Key Executives Interviewed
